CHR
Cheer Holding, Inc.
There isn't enough reported data to score CHR yet.
NBIS
Nebius Group N.V.
There isn't enough reported data to score NBIS yet.
CHR Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| Stable | |
| Healthy |
CHR's profitability and balance sheet are currently healthy, and its cash flow is stable, but its revenue is under pressure.
NBIS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Healthy |
NBIS's profitability and balance sheet are currently healthy. There isn't enough data to rate its revenue and cash flow.
CHR PE Valuation
CHR has no meaningful PE right now: it lost money over the past year.
NBIS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 68x | $22.45 | -83% |
| Fair | 114x | $37.67 | -71% |
| Current | 390x | $129 | โ |
| Expensive | 666x | $220 | +71% |
Historical ranges are pointers, not guarantees.
NBIS's PE is 390x, but its earnings don't support one, so it isn't a reliable read right now.
CHR Forward outlook
There aren't enough analyst estimates for CHR to show an outlook.
NBIS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect NBIS's revenue to grow and its profitability to improve, with its earnings holding steady. However, they disagree widely on these estimates.
CHR Earnings Per Share
CHR and NBIS do not have enough comparable growth data to identify a winner.
NBIS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $0.33 | +$2.61 |
| Q4 2024 | -$2.28 | -456% |
| Q4 2023 | $0.64 | -36% |
| Q4 2022 | $1.00 | +$1.49 |
| Q4 2021 | -$0.49 | -156% |
| Q4 2020 | $0.87 | +89% |
| Q4 2019 | $0.46 | -73% |
| Q4 2018 | $1.71 | +434% |
NBIS has returned to profit: it earned $0.33 per share over the past year, after losing money the year before.
CHR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $30.3M | -15% |
| Q1 2026 | $30.3M | -15% |
| Q4 2025 | $38.9M | +2.2% |
| Q3 2025 | $38.9M | +2.2% |
| Q2 2025 | $35.5M | -50% |
| Q4 2024 | $38.1M | -55% |
| Q2 2024 | $71.1M | +5.4% |
| Q4 2023 | $84.9M | -2.6% |
CHR has the edge over NBIS in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 17% | +5.6 points |
| Q1 2026 | 17% | +5.6 points |
| Q4 2025 | 23% | +4.8 points |
| Q3 2025 | 23% | +4.8 points |
| Q2 2025 | 12% | -4.6 points |
| Q1 2025 | 12% | N/A |
| Q4 2024 | 18% | -5.9 points |
| Q3 2024 | 18% | N/A |
CHR's operating margin was 17% last quarter, up 5.6 points from the same quarter a year ago.
NBIS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2023 | $9.7B | +53% |
| Q4 2022 | $6.3B | +46% |
| Q4 2021 | $4.3B | +63% |
| Q4 2020 | $2.6B | +24% |
| Q4 2019 | $2.1B | +37% |
| Q4 2018 | $1.5B | +36% |
| Q4 2017 | $1.1B | +24% |
| Q4 2016 | $917M | +27% |
NBIS's revenue is growing: $530M last quarter, down 80% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -115% | -112 points |
| Q4 2023 | 3.6% | -11 points |
| Q4 2022 | 2.5% | -14 points |
| Q4 2021 | -3.7% | -18 points |
| Q4 2020 | 7.4% | -9.5 points |
| Q4 2019 | 14% | -2 points |
| Q4 2018 | 16% | -14 points |
| Q4 2017 | 14% | -19 points |
NBIS's operating margin was โ115% last quarter, down 123 points from the same quarter a year ago, near the bottom of its range since 2011.
CHR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$15.1M | -871% |
| Q1 2026 | $17.9M | +815% |
| Q4 2025 | $7M | -53% |
| Q3 2025 | $7M | -53% |
| Q2 2025 | $2M | +$8.7M |
| Q1 2025 | $2M | +$5.3M |
| Q4 2024 | $14.8M | -1.3% |
| Q3 2024 | $14.8M | +97% |
CHR usually generates cash, though not every quarter: the latest was โ$15M, but it generated $17M over the past year.
NBIS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$3.7B | -$3.1B |
| Q4 2024 | -$562.1M | -$316.2M |
| Q4 2023 | -$245.9M | -$138.9M |
| Q4 2022 | -$107M | +$319.7M |
| Q4 2021 | -$426.7M | -539% |
| Q4 2020 | $97.3M | -66% |
| Q4 2019 | $287.9M | +$289.2M |
| Q4 2018 | -$1.3M | -101% |
NBIS has burned cash in six of the last eight quarters: โ$4.6B over the past year, against โ$43M the year before.
CHR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -4.8x | Net Cash |
| Q1 2026 | -5.0x | Net Cash |
| Q4 2025 | -6.7x | Net Cash |
| Q3 2025 | -7.6x | Net Cash |
| Q2 2025 | -7.5x | Net Cash |
| Q1 2025 | -5.7x | Net Cash |
CHR has more cash than debt.
NBIS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | 0.7x | Very low |
| Q4 2022 | -0.7x | Net Cash |
NBIS's net debt is less than a year of its operating earnings (EBITDA).
CHR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 25.6 | Oversold |
| Stochastic | 15.4 | Oversold |
CHR's weekly RSI is 26 (oversold) and its Stochastic is 15 (oversold).
NBIS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 8.3 | Oversold |
NBIS's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).
CHR PE vs Communication Services Sector
CHR has no meaningful PE right now: it lost money over the past year.
NBIS PE vs Communication Services Sector
| Metric | NBIS | Sector median | Relative |
|---|---|---|---|
| PE | 390x | 16x | 2,264% above |
| PE % | 62 | 24 | 38 pts above |
NBIS is trading at 390x earnings, a 2264% premium to the Communication Services sector's median of 16x, though its earnings don't support one.
CHR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.43 | 7.7% below |
| 20 week MA | $1.67 | 21% below |
| 50 week MA | $2.59 | 49% below |
| 100 week MA | $103.9 | 99% below |
| 200 week MA | $363.1 | 100% below |
NBIS has stronger trend alignment. CHR is above 0 of 5 weekly averages versus NBIS above 1 of 4.
NBIS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $179.7 | 28% below |
| 20 week MA | $199.9 | 36% below |
| 50 week MA | $163.5 | 21% below |
| 100 week MA | $110.0 | 17% above |
NBIS has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 17% above its 100-week average.
CHR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15,450.0 | $3,945.0 | -74% |
| 2021 | $3,945.0 | $1,935.0 | -51% |
| 2022 | $1,935.0 | $2,220.0 | +15% |
| 2023 | $2,220.0 | $471.0 | -79% |
| 2024 | $471.0 | $387.0 | -18% |
| 2025 | $387.0 | $4.38 | -99% |
| 2026 YTD | $4.38 | $1.32 | -70% |
CHR has finished three years in a row lower, and it's down 70% so far in 2026.
NBIS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $19.6 | $27.3 | +40% |
| 2025 | $27.3 | $87.6 | +221% |
| 2026 YTD | $87.6 | $128.6 | +47% |
NBIS has the edge over CHR on returns for 2026, with the stronger performance.